Position in CELC
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$15,202,419
+$4,731,117 QoQ
Shares Held
133,191
+26.9% QoQ
Ownership
0.273%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 88.37834388209413.ToString("F0")%
None 11.621656117905864.ToString("F0")%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026VOYA INVESTMENT MANAGEMENT LLC holds $1,306,795,205 across 174 Biotechnology names. CELC ranks #19 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
349,912 | $270,356,007 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
527,047 | $235,347,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
148,488 | $49,130,223 | |
| 4 | PTGX |
Protagonist Therapeutics, Inc
|
454,383 | $47,891,967 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
656,129 | $41,139,286 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
538,980 | $40,024,653 | |
| 7 | INSM |
INSMED Inc
|
243,706 | $39,850,804 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
725,409 | $35,661,105 |
All Filings in CELC
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,202,419 | 133,191 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $10,471,302 | 104,986 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $2,145,096 | 43,423 | Shares | Defined | 2025-10-09 | |
| No filing history on record for this holder in this stock. | ||||||